You would be excused for supposing that Talecris Biotherapeutics, Inc., founded on April 1, 2005, is a young company. In truth, though, its roots go much deeper - both scientifically and into the North Carolina Piedmont - than might be obvious at first glance. Talecris was formed when two private investment firms provided the capital to acquire the blood-plasma business of Bayer HealthCare LLC's Biological Products Division. Among those assets were Bayer's state-of-the-art Clayton, NC, blood plasma-therapeutics production facility and its headquarters in Research Triangle Park (RTP).
But Talecris acquired much more than buildings, equipment, and products from Bayer. Along with those tangible assets came a 60-year history of providing life-saving products for patients with rare diseases, and a workforce with the ability and experience to build upon a legacy of innovation. In fact, the company's name reflects just those values. A combination of top industry TALEnt, focused on the ...
